Ronald Thomas Hay - Curriculum Vitae#

A full list of publications can be found at:

  • B.Sc. with 1st. Class Honours in Biochemistry, Heriot-Watt University, Edinburgh. 1971-1975.
  • Ph.D. Thesis entitled "DNA binding proteins and DNA synthesis in herpesvirus infected cells". Advisor Dr. John Hay (no relation). Institute of Virology, University of Glasgow. 1975-1979

  • 1979-1982 Damon Runyon-Walter Winchell Cancer Fund Postdoctoral Fellow in the laboratory of Dr. M.L. DePamphilis, Department of Biological Chemistry, Harvard Medical School, Boston, U.S.A.. Working on the Initiation of simian virus 40 DNA replication.
  • 1982-1985 Member of the scientific staff of the Medical Research Council Virology Unit, Institute of Virology, University of Glasgow. Working on the initiation of adenovirus DNA replication.
  • 1985-1991 Lecturer in Department of Biochemistry and Microbiology, University of St. Andrews..
v1991-1994 Reader in Department of Biochemistry and Microbiology, University of St. Andrews.
  • 1994-2005 Professor of Molecular Biology in the School of Biology, University of St Andrews.
  • 2005- present Professor of Molecular Biology in the College of Life Sciences, Division of Gene Regulation and Expression, University of Dundee
  • 2008- present. Honorary member of the Scottish Institute for Cell Signaling (SCILLS)

University responsibilities
  • Head of the Division of Cell and Molecular Biology, University of St Andrews (1993-1997)
  • Chairman for the Irvine Building. University of St Andrews (1993-1998)
  • Deputy Director of the Centre for Biomolecular Sciences, University of St Andrews (1999-2005)

  • Fellow of the Royal Society
  • Fellow of the Royal Society of Edinburgh.
  • Fellow of the Academy of Medical Sciences
  • Member of the European Molecular Biology Organisation
  • Member of the Cancer Research UK Programmes Committee (1999-2008).
  • Member of the Biomedical and Therapeutic Research Committee of the Scottish Executive (2002-)
  • Member of Council, Society for General Microbiology (1995-1999).
  • Royal Society Research Grants Scheme, Board E (2008-)
  • Clinical Fellowships Committee Cancer Research UK (2007-)

Current Funding
  • R.T. HAY GSK £700,000. siRNA screening in oncology 01/01/10- 31/12/12.
  • R.T. HAY CR-UK £1,300,000. The role of SUMO modification in stress responses. 01/12/06 – 30/11/11.
  • R.T. HAY MRC £930,000. Determining the role of the SUMO – specific ubiquitin ligase Rnf4. 01/06/08 – 01/06/12.
  • R.T. HAY BBSRC £345,550. Structure and function of the SUMO specific protease SENP7. 01/12/07 – 30/11/10.
  • A. I. LAMOND, HAY, R.T., SWEDLOW, J., BLOW, J.J. and HUTVAGNER, G. Wellcome Trust (purchase of an Orbitrap mass spectrometer + RA) £494,492 Quantitative Mass Spectrometry Analysis of Gene Expression and Protein Dynamics. 01/04/07 – 31/03/12.
R. T. HAY (and 19 others, M. MASUCCI co-ordinator). EU FPVI. 12M Euro total, 438, 000 Euro (Dundee component). Network of Excellence. Role of Ubiquitin and ubiquitin-like modifiers in cellular regulation (RUBICON). 01/01/06 - 01/01/11.

Training: Over 40 postdoctoral fellows and 17 PhD students have been trained
Imprint Privacy policy « This page (revision-2) was last changed on Monday, 8. October 2012, 12:57 by Kaiser Dana
  • operated by